JAK2 V617F-Dependent Upregulation of PU.1 Expression in the Peripheral Blood of Myeloproliferative Neoplasm Patients

• Tamotsu Irino,

  Affiliations Shiga Medical Center for Adults, Moriyama, Japan, Division of Medical Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan

  ⨯
• Munehiro Uemura,

  Affiliation Shiga Medical Center Research Institute, Moriyama, Japan

  ⨯
• Humitsugu Yamane,

  Affiliation Department of Environmental and Preventive Medicine, Shimane University School of Medicine, Izumo, Japan

  ⨯
• Shigeto Umemura,

  Affiliation Shiga Medical Center for Adults, Moriyama, Japan

  ⨯
• Takahiko Utsumi,

  Affiliation Shiga Medical Center for Adults, Moriyama, Japan

  ⨯
• Naoki Kakazu,

  Affiliation Department of Environmental and Preventive Medicine, Shimane University School of Medicine, Izumo, Japan

  ⨯
• Taku Shirakawa,

  Affiliation Division of Medical Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan

  ⨯
• Mitsuhiro Ito,

  Affiliation Division of Medical Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan

  ⨯
• Takayo Suzuki,

  Affiliation Shiga Medical Center for Adults, Moriyama, Japan

  ⨯
• Kazuo Kinoshita

  * E-mail: kkinoshi.shigamed@mac.com

  Affiliation Shiga Medical Center Research Institute, Moriyama, Japan

  ⨯